Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) provides products and services for pharmaceutical and biotechnology companies, hospitals, clinical diagnostic laboratories, universities, research institutions, government agencies, and environmental, industrial, research and quality-control settings. Its offerings include… From the company’s description.
In fiscal 2025, Thermo Fisher Scientific reported revenue of $44.56B, up 3.9% from fiscal 2024, and net income of $6.72B. Its operating margin was 17.4%, and operations generated $7.82B in cash. Over the twelve months to Jun 27, 2026, revenue was $46.34B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Thermo Fisher Scientific does
In the company’s own words
Thermo Fisher Scientific Inc. (NYSE: TMO) provides products and services for pharmaceutical and biotechnology companies, hospitals, clinical diagnostic laboratories, universities, research institutions, government agencies, and environmental, industrial, research and quality-control settings. Its offerings include laboratory and analytical instruments, reagents, consumables, diagnostic tests, software and support, along with drug development, clinical research, clinical trial and commercial manufacturing services. The company reports four segments: Life Sciences Solutions, which supplies research, genetic science and bioproduction tools; Analytical Instruments, covering chromatography and mass spectrometry, chemical analysis and electron microscopy; Specialty Diagnostics, providing diagnostic tests, reagents and laboratory products; and Laboratory Products and Biopharma Services, spanning laboratory supplies, distribution, pharmaceutical services and clinical research. Major brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Thermo Fisher employed approximately 125,000 people worldwide as of December 31, 2025. Its website is http://www.thermofisher.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- WALTHAM, MA
- Fiscal year end
- December
- CIK
- 97745
- SIC
- 3829
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Thermo Fisher Scientific — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Thermo Fisher Scientific · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Thermo Fisher Scientific’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Thermo Fisher Scientific’s bonds, as funds hold them
Funds report holding 36 issues of Thermo Fisher Scientific’s debt, $2.39B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.17%, maturing 2026 to 2049.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Thermo Fisher Scientific and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Thermo Fisher Scientific's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Thermo Fisher Scientific's last four quarterly filings that the numbers alone won't show?”